| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |